Creative Planning Vaxxinity, Inc. Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.62 - $0.86 $1,099 - $1,524	1,773 Added 0.62%	286,862 $206,000
Q4 2023 Feb 14, 2024	BUY	$0.7 - $1.31 $4,510 - $8,440	6,443 Added 2.31%	285,089 $242,000
Q3 2023 Nov 16, 2023	SELL	$1.25 - $3.0 $998 - $2,397	-799 Reduced 0.29%	278,646 $381,000
Q4 2022 Feb 10, 2023	SELL	$1.31 - $2.62 $1,310 - $2,620	-1,000 Reduced 0.36%	279,445 $391,000
Q3 2022 Nov 03, 2022	BUY	$1.64 - $2.48 $4,795 - $7,251	2,924 Added 1.05%	280,445 $555,000
Q2 2022 Aug 15, 2022	BUY	$1.55 - $6.95 $430,157 - $1.93 Million	277,521 New	277,521 $436,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.